Aspirin sensitivity and the nose

British Journal of Hospital Medicine

Volumn 71, Issue 8, 2010, Pages 442-445

  Douglas, G C ^a   Karkos, P D ^b   Swift, A C ^c  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b Otolaryngology   (United Kingdom)

^c UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955946903     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2010.71.8.77666     Document Type: Conference Paper

References (30)

1. Awad OG, Lee JH, Fasano MB, Graham SM. (2008) Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirininduced asthma? Laryngoscope 118(7): 1282-6
2. Berges-Gimeno MP, Simo RA, Stevenson DD (2003) Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 111(1): 180-6
3. Flower R (2003) What are all the things that aspirin does? BMJ 327(7415): 572-3
4. Fokkens W, Lund V, Mullol J (2007) European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl (20): 1-136
5. Gosepath J, Schafer D, Mann WJ (2002) [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day]. Laryngorhinootologie 81(10): 732-8
6. Jantti-Alanko S, Holopainen E, Malmberg H (1989) Recurrence of nasal polyps after surgical treatment. Rhinol Suppl 8: 59-64
7. Jenkins C, Costello J, Hodge L (2004) Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 328 (7437): 434
8. Katotomichelakis M, Riga M, Davris S et al (2009) Allergic rhinitis and aspirin-exacerbated respiratory disease as predictors of the olfactory outcome after endoscopic sinus surgery. Am J Rhinol Allergy 23(3): 348-53
9. Kim JE, Kountakis SE (2007) The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 86(7): 396-9
10. Kowalski ML, Grzegorczyk J, Pawliczak R, Kornatowski T, Wagrowska-Danilewicz M, Danilewicz M (2002) Decreased apoptosis and distinct profile of infiltrating cells in die nasal polyps of patients with aspirin hypersensitivity. Allergy 57(6): 493-500
11. Lee JY, Simon RA, Stevenson DD (2007) Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 119(1): 157-64
12. Macy E, Bernstein JA, Castells MC et al (2007) Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 98(2): 172-4
13. McGeehan M, Bush RK (2002) The mechanisms of aspirin-intolerant asthma and its management. Curr Allergy Asthma Rep 2(2): 117-25
14. McMains KC, Kountakis SE (2006) Medical and surgical considerations in patients with Samter's triad. Am J Rhinol 20(6): 573-6
15. Ogata N, Darby Y, Scadding G (2007) Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma J Laryngol Otol 121(12): 1156-60
16. Parikh AA, Scadding GK (2005) Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 115(8): 1385-90
17. Parnes SM (2003) The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg 11(3): 184-91
18. Pfaar O, Klimek L (2006) Eicosanoids, aspirin-intolerance and the upper airways-current standards and recent improvements of the desensitization therapy. J Physiol Pharmacol 57(Suppl 12): 5-13
19. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schat M, Zeiger RS (1983) Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 71(6): 574-9
20. Rosado A, Vives R, Gonzalez R, Rodriguez J (2003) Can NSAIDs intolerance disappear? A study of three cases. Allergy 58(7): 689-90
21. Samter M, Beers RF (1968) Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68(5): 975-83
22. Stevenson DD, Simon RA, Mathison DA (1980) Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 66(1): 82-8
23. Stevenson DD, Pleskow WW, Simon RA, Mathison DA, Lumry WR, Schatz M, Zeiger RS (1984) Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol 73(4): 500-7
24. Stevenson DD, Sanchez-Borges M, Szczeklik A (2001) Classification of allergic and. Pseudoallergic reactions to drugs that inhibit cydooxygenase enzymes. Ann Allergy Asthma Immunol 87(3): 177-80
25. Szczeklik A, Gryglewski RJ, Czemiawska-Mysik G (1975) Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1(5949): 67-9
26. Szczeklik A, Nizankowska E (2000) Clinical features and diagnosis of aspirin induced asthma. Thorax 55 (Suppl 2): S42-S44
27. Szczeklik A, Stevenson DD (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111(5): 913-21.
28. Widal MF, Abrami P, Lenmoyez J (1922) Anaphylaxie et idiosyncrasie. Presse Med 30: 189-92
29. Williams AN, Woessner KM (2008) The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. Curr Allergy Asthma Rep 8(3): 245-52
30. Zeiss CR, Lockey RF (1976) Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 57(5): 4408